US Patent 11534453 RNAi therapy for hepatitis B virus infection
Patent 11534453 was granted and assigned to Arrowhead Pharmaceuticals, Inc. on December, 2022 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11534453 RNAi therapy for hepatitis B virus infection
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.